TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $413,000 | -64.1% | 859,322 | 0.0% | 0.02% | -63.8% |
Q1 2019 | $1,151,000 | +18.5% | 859,322 | 0.0% | 0.05% | +11.9% |
Q4 2018 | $971,000 | -59.1% | 859,322 | 0.0% | 0.04% | -51.2% |
Q3 2018 | $2,372,000 | -22.7% | 859,322 | 0.0% | 0.09% | -25.9% |
Q2 2018 | $3,068,000 | +16.3% | 859,322 | 0.0% | 0.12% | +12.6% |
Q1 2018 | $2,638,000 | -51.3% | 859,322 | 0.0% | 0.10% | -50.7% |
Q4 2017 | $5,414,000 | -7.9% | 859,322 | 0.0% | 0.21% | -0.5% |
Q3 2017 | $5,878,000 | -17.9% | 859,322 | -14.4% | 0.21% | -20.8% |
Q2 2017 | $7,161,000 | -22.4% | 1,004,322 | 0.0% | 0.26% | -26.0% |
Q1 2017 | $9,230,000 | +1091.0% | 1,004,322 | +422.2% | 0.36% | +984.8% |
Q4 2016 | $775,000 | +5.2% | 192,322 | 0.0% | 0.03% | +17.9% |
Q3 2016 | $737,000 | -10.9% | 192,322 | 0.0% | 0.03% | -17.6% |
Q2 2016 | $827,000 | -7.1% | 192,322 | 0.0% | 0.03% | -10.5% |
Q1 2016 | $890,000 | -53.9% | 192,322 | 0.0% | 0.04% | -45.7% |
Q4 2015 | $1,929,000 | +34.4% | 192,322 | 0.0% | 0.07% | +34.6% |
Q3 2015 | $1,435,000 | – | 192,322 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
Man Group plc | 737,715 | $2,634,000 | 0.01% |